Abstract
Elevated concentrations of C-reactive protein (CRP) and decreased concentrations of triiodothyronine (T3) were shown to predict poor outcomes in patients with stroke. However, the prognostic value of CRP and T3 has not been studied simultaneously in relation to stroke functional and cognitive outcomes despite of close interaction between inflammatory markers and thyroid function. We evaluated the association of thyroid hormone and CRP concentrations with immediate outcomes after ischemic stroke. Eighty-eight ischemic stroke patients on admission to the stroke unit were evaluated for clinical stroke severity (Scandinavian stroke scale or SSS) and concentrations of thyroid-stimulating hormone, free thyroxin, free T3, and CRP. Functional outcome (modified Rankin scale) and cognitive outcome (Mini mental state examination) were evaluated at discharge. Greater ln CRP concentrations (r = −0.35, p = 0.001), but not thyroid hormone concentrations, correlated with score on the SSS. In univariate analyses lower free T3 concentrations and higher CRP concentrations were associated with poor functional and poor cognitive outcomes. After adjustment for clinical stroke severity, higher CRP concentrations (β = 0.18, p = 0.04) remained associated with worse functional outcome and lower free T3 concentrations with worse cognitive outcome (β = 0.23, p = 0.03). In sum, clinical stroke severity is associated with elevated CRP concentration. Higher CRP concentration is independently associated with worse functional outcomes and lower free T3 concentration with worse cognitive outcomes at discharge. T3 and CRP can be important biomarkers in patients with acute ischemic stroke.
Similar content being viewed by others
References
A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler, C.S. Moy, M.E. Mussolino, G. Nichol, N.P. Paynter, P.J. Schreiner, P.D. Sorlie, J. Stein, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner, Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127, e6–e245 (2013)
Prvu Bettger, J., Alexander, K.P., Dolor, R.J., Olson, D.M., Kendrick, A.S., Wing, L., Coeytaux, R.R., Graffagnino, C., Duncan, P.W.: Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review. Ann. Intern. Med. 157, 407–416 (2012)
P.D. Lyden, L. Hantson, Assessment scales for the evaluation of stroke patients. J. Stroke. Cerebrovasc. Dis. 7, 113–127 (1998)
A.K. Saenger, R.H. Christenson, Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin. Chem. 56, 21–33 (2010)
M.H. Warner, G.J. Beckett, Mechanisms behind the non-thyroidal illness syndrome: an update. J. Endocrinol. 205, 1–13 (2010)
M. Fontana, C. Passino, R. Poletti, L. Zyw, C. Prontera, M. Scarlattini, A. Clerico, M. Emdin, G. Iervasi, Low triiodothyronine and exercise capacity in heart failure. Int. J. Cardiol. 154, 153–157 (2012)
A. Bunevicius, V. Gintauskiene, A. Podlipskyte, R. Zaliunas, J. Brozaitiene, A.J. Prange Jr, R. Bunevicius, Fatigue in patients with coronary artery disease: association with thyroid axis hormones and cortisol. Psychosom. Med. 74(8), 848–853 (2012)
J. L. Leonard, J. Koehrle, in Intracellular pathways of iodothyronine metabolism, ed. by Werner, Ingbar, The thyroid: A fundamental and clinical text, 7th edn. (Lippincott-Raven Publishers, Philadelphia, 1996) pp. 136–173
R. Bunevicius, A.J. Prange Jr, Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr. Opin. Psychiatry. 23(4), 363–368 (2010)
A. Bunevicius, V. Deltuva, S. Tamasauskas, A. Tamasauskas, E.R. Laws Jr, R. Bunevicius, Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study. J. Neurosurg. (2013). doi:10.3171/2013.1.JNS121696
K. Plikat, J. Langgartner, R. Buettner, L.C. Bollheimer, U. Woenckhaus, J. Scholmerich, C.E. Wrede, Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism. 56, 239–244 (2007)
S.D. Marks, C. Haines, I.M. Rebeyka, R.M. Couch, Hypothalamic–pituitary–thyroid axis changes in children after cardiac surgery. J. Clin. Endocrinol. Metab. 94(8), 2781–2786 (2009)
M. Alevizaki, M. Synetou, K. Xynos, T. Pappa, K.N. Vemmos, Low triiodothyronine: a strong predictor of outcome in acute stroke patients. Eur. J. Clin. Investig. 37, 651–657 (2007)
W. Ambrosius, R. Kazmierski, V. Gupta, A.W. Warot, D. Adamczewska-Kocialkowska, A. Blazejewska, K. Ziemnicka, W.L. Nowinski, Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke. Exp. Clin. Endocrinol. Diabetes 119, 139–143 (2011)
S. Neidert, M. Katan, P. Schuetz, F. Fluri, A. Ernst, R. Bingisser, L. Kappos, S.T. Engelter, A. Steck, B. Muller, M. Christ-Crain, Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J. Intern. Med. 269, 420–432 (2011)
S. Melkas, N.K. Oksala, H. Jokinen, T. Pohjasvaara, R. Vataja, A. Oksala, M. Kaste, P.J. Karhunen, T. Erkinjuntti, Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke. J. Neurol. Neurosurg. Psychiatry 80(8), 865–870 (2009)
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H.C. Emsley, S. Forconi, S.J. Hopkins, L. Masotti, K.W. Muir, A. Paciucci, F. Papa, S. Roncacci, D. Sander, K. Sander, C.J. Smith, A. Stefanini, D. Weber, Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36, 1316–1329 (2005)
H.M. den Hertog, J.A. van Rossum, H.B. van der Worp, H.M. van Gemert, R. de Jonge, P.J. Koudstaal, D.W. Dippel, C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J. Neurol. 256, 2003–2008 (2009)
J. Gunstad, L. Bausserman, R.H. Paul, D.F. Tate, K. Hoth, A. Poppas, A.L. Jefferson, R.A. Cohen, C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J. Clin. Neurosci. 13, 540–546 (2006)
T. van der Poll, J.A. Romijn, W.M. Wiersinga, H.P. Sauerwein, Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab. 71, 1567–1572 (1990)
H.A. Abo-Zenah, S.A. Shoeb, A.A. Sabry, H.A. Ismail, Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC. Endocr. Disord. 8, 1 (2008)
C. Jublanc, E. Bruckert, P. Giral, M.J. Chapman, L. Leenhardt, V. Carreau, G. Turpin, Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. Atherosclerosis. 172, 7–11 (2004)
E. Lindenstrom, G. Boysen, L.W. Christiansen, B.R. Hansen, P.W. Nielsen, Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc. Dis. 1, 103–107 (1991)
R. Bonita, R. Beaglehole, Recovery of motor function after stroke. Stroke 19, 1497–1500 (1988)
H.P. Adams Jr, B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, E.E. Marsh 3rd, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993)
J.L. Banks, C.A. Marotta, Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38(3), 1091–1096 (2007)
M.F. Folstein, S.E. Folstein, P.R. McHugh, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975)
S. Meyer, P. Schuetz, M. Wieland, C. Nusbaumer, B. Mueller, M. Christ-Crain, Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? Endocrine 39(2), 167–174 (2011)
D.F. Gardner, R.L. Carithers Jr, R.D. Utiger, Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann. Intern. Med. 96, 450–452 (1982)
S. Bao, R. Oiknine, S.J. Fisher, Differentiating nonthyroidal illness syndrome from central hypothyroidism in the acutely ill hospitalized patient. Endocrine 42, 758–760 (2012)
A. Boelen, J. Kwakkel, O. Chassande, E. Fliers, Thyroid hormone receptor beta mediates acute illness-induced alterations in central thyroid hormone metabolism. J. Neuroendocrinol. 21, 465–472 (2009)
L. Sui, W.W. Ren, B.M. Li, Administration of thyroid hormone increases reelin and brain-derived neurotrophic factor expression in rat hippocampus in vivo. Brain Res. 1313, 9–24 (2010)
L.H. Pitts, A. Ross, G.A. Chase, A.I. Faden, Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J. Neurotrauma 12, 235–243 (1995)
I. Margaill, J. Royer, D. Lerouet, M. Ramauge, C. Le Goascogne, W.W. Li, M. Plotkine, M. Pierre, F. Courtin, Induction of type 2 iodothyronine deiodinase in astrocytes after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 25, 468–476 (2005)
W.M. van der Deure, B.C. Appelhof, R.P. Peeters, W.M. Wiersinga, E.M. Wekking, J. Huyser, A.H. Schene, J.G. Tijssen, W.J. Hoogendijk, T.J. Visser, E. Fliers, Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin Endocrinol (Oxf). 69, 804–811 (2008)
C.E. Schwartz, R.E. Stevenson, The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome Best. Pract. Res. Clin. Endocrinol. Metab. 21, 307–321 (2007)
R. Gill, J.A. Kemp, C. Sabin, M.B. Pepys, Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J. Cereb. Blood Flow Metab. 24, 1214–1218 (2004)
P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr, J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, R.J. Glynn, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008)
Acknowledgments
We thank Dr. David Y. Huang, MD, PhD, from the Department of Neurology, University of North Carolina at Chapel Hill for his valuable comments regarding this article. This research was funded by the European Social Fund under the Global Grant measure (contract number: VP1-3.1-SMM-07-K-02-060).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bunevicius, A., Kazlauskas, H., Raskauskiene, N. et al. Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. Endocrine 45, 213–220 (2014). https://doi.org/10.1007/s12020-013-9958-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9958-2